Evaluation of Chronic and Acute Beetroot Juice Supplementation on Submaximal VO2 in High-Level Athletes
The goal of this randomized crossover clinical trial is to determine whether acute or subacute nitrate supplementation with concentrated beetroot juice improves submaximal exercise performance in elite athletes. The optimal nitrate supplementation regimen using concentrated beetroot juice has not yet been clearly established. The main questions it aims to answer are:
- Does subacute nitrate supplementation, consisting of seven days of twice-daily Beet It Sport consumption followed by an additional dose on the morning of testing, improve submaximal exercise performance compared with acute nitrate supplementation alone?
- Does subacute nitrate supplementation result in greater improvements in submaximal oxygen consumption (VO₂), time to exhaustion, and physiological responses during exercise than acute nitrate supplementation?
Researchers will compare the two nitrate supplementation regimens in the same athletes to determine which approach provides the greatest improvement in submaximal exercise performance. Participants will be randomly assigned to one of two groups, each completing both supplementation regimens in a different order, with a 2-4-week washout period between interventions to minimize potential carryover effects.
Participants will:
- Complete the recruitment and informed consent process.
- Attend three study visits, including an initial VO₂ max assessment and subsequent exercise testing visits.
- Complete both supplementation regimens in a randomized crossover design:
- Subacute nitrate supplementation: Consume 70 mL of Beet It Sport twice daily for seven days before the exercise test, followed by 140 mL on the morning of the test.
- Acute nitrate supplementation: Consume 70 mL of placebo twice daily for seven days before the exercise test, followed by 140 mL of Beet It Sport on the morning of the test.
- Undergo exercise testing, including submaximal VO₂ assessment and a time-to-exhaustion test, as well as measurements of vital signs and capillary blood lactate levels.
- Complete a questionnaire assessing adherence to the assigned supplementation regimen.
No additional follow-up will be required after the study visits. The findings may help establish the most effective nitrate supplementation regimen using concentrated beetroot juice to optimize submaximal exercise performance in elite athletes.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Sherbrooke, Quebec, Canada, J1G 2Y9
- Université de Sherbrooke
-
Contact:
- Benoit Genest
- Phone Number: 4506014311
- Email: benoit.genest2@usherbrooke.ca
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult male or female aged 30 years or younger
- Active member of the University of Sherbrooke Vert & Or cross-country or athletics team, or the Sherbrooke Athletics Club
Exclusion Criteria:
- Daily beetroot juice consumption
- Injury limiting participation in competitions or training
- Beetroot or lemon allergy
- Known cardiac, pulmonary, or metabolic disease except treated asthma
- Use of medications other than contraceptives or asthma inhalers
- Smoking or vaping
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Acute Administration First
Acute first |
Complete both supplementation regimens in a crossover design:
|
|
Other: Subacute First
Subacute first |
Complete both supplementation regimens in a randomized crossover design:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Submaximal exercise test
Time Frame: 1 hours
|
V02 max |
1 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to exhaustion test
Time Frame: 1 hour
|
Time in secondes |
1 hour
|
|
Capillary blood lactate concentrations during exercise testing
Time Frame: 1 hour
|
(mmol/L) |
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2027-6544
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.